J05AP: Antivirals for treatment of HCV infections
Explore J05AP Antivirals for treatment of HCV infections in the ATC classification system. Part of J Antiinfectives for Systemic Use > J05 Antivirals for Sys...
About Antivirals for treatment of HCV infections
J05AP Antivirals for treatment of HCV infections is part of the WHO ATC classification system and belongs to J Antiinfectives for Systemic Use > J05 Antivirals for Systemic Use > J05A Direct Acting Antivirals. This chemical subgroup page helps users identify more specific classifications and related active ingredients associated with this ATC code. It also includes 19 related active ingredients, supporting deeper navigation across ingredient-level pages. Use this page to explore the ATC hierarchy, review connected groups, and find relevant ingredient pages within Pharmassive.
Active Ingredients in Antivirals for treatment of HCV infections
Asunaprevir
View ingredient details →
BoceprevirView ingredient details →
DaclatasvirView ingredient details →
Daclatasvir, Asunaprevir and BeclabuvirView ingredient details →
DasabuvirView ingredient details →
Dasabuvir, Ombitasvir, Paritaprevir and RitonavirView ingredient details →
ElbasvirView ingredient details →
Elbasvir and Grazoprevir Standard DoseView ingredient details →
FaldaprevirView ingredient details →
Glecaprevir and Pibrentasvir Standard DoseView ingredient details →
GrazoprevirView ingredient details →
Ombitasvir, Paritaprevir and Ritonavir Standard DoseView ingredient details →
RibavirinView ingredient details →
SimeprevirView ingredient details →
SofosbuvirView ingredient details →
Sofosbuvir and Ledipasvir Standard DoseView ingredient details →
Sofosbuvir and Velpatasvir Standard DoseView ingredient details →
Sofosbuvir, Velpatasvir and Voxilaprevir Standard DoseView ingredient details →
TelaprevirView ingredient details →